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Insulin regulation of protein translation repressor 4E-BP1, an tion, and termination, is affected and regulated by dis-
eIF4E-binding protein, in renal epithelial cells. tinct factors [1]. Among the regulatory factors, eukaryo-
Background. Augmented protein translation by insulin in- tic initiation factor 4E (eIF4E) and its binding proteinvolves activation of eukaryotic initiation factor 4E (eIF4E)
4E-BP1 have received the most attention. eIF4E, a 24that follows release of eIF4E from a heterodimeric complex
kD protein, the least abundant of the initiation factors inby phosphorylation of its inhibitory binding protein, 4E-BP1.
We examined insulin regulation of 4E-BP1 phosphorylation in most mammalian cells, forms a heterotrimer, the eIF4F
murine proximal tubular epithelial cells. complex, with two other factors, eIF4A and eIF4G [2].
Methods and Results. Insulin (1 nmol/L) increased de novo In resting cells, eIF4E is held inactive in a complex withprotein synthesis by 58 6 11% (P , 0.001). Insulin also aug-
its binding protein 4E-BP1 and is released by phosphory-mented 4E-BP1 phosphorylation and phosphatidylinositol
lation of the latter [3, 4]. eIF4E forms eIF4F complex3-kinase (PI 3-kinase) activity in antiphosphotyrosine immuno-
precipitates. This could be prevented by PI 3-kinase inhibitors, by binding with eIF4A and eIF4G. After eIF4F binds
Wortmannin, and LY294002. Insulin also activated Akt that to the methylated cap of the mRNA and recruits the
lies downstream of PI 3-kinase. Rapamycin abrogated 4E-BP1
rest of the translational machinery, the ability of the 43Sphosphorylation in response to insulin, suggesting involvement
ribosomal complex to scan the mRNA for the AUGof mammalian target of rapamycin (mTOR), a kinase down-
stream of Akt. Insulin-stimulated phosphorylation of 4E-BP1 codon to initiate protein synthesis is inhibited if there
was also inhibited by PD098059, implying involvement of are secondary structures in the 59 untranslated region
Erk-1/-2 mitogen-activated protein (MAP) kinase. An increase in (UTR), that is, stem loops formed by excessive guanine
Erk-1/-2 type MAP kinase activity by insulin was directly con-
cytosine (GC) residues. The RNA helicase activity offirmed in an immunokinase assay and was found to be PI 3-kinase
eIF4A (of eIF4F complex) melts the secondary struc-dependent.
Conclusions. In proximal tubular epithelial cells, insulin tures, allowing the 43S ribosome to scan the mRNA
augments 4E-BP1 phosphorylation, which is PI 3-kinase and efficiently and to initiate translation [2]. Thus, the cap-
mTOR dependent. The requirement for Erk-1/-2 MAP kinase binding function of the eIF4E is particularly importantactivation for 4E-BP1 phosphorylation by insulin suggests a
in translation of mRNAs that have a secondary struc-cross-talk between PI 3-kinase and Erk-1/-2–type MAP kinase
ture in their 59 UTR, for example, ornithine decarboxy-pathways.
lase [5].
Activation of eIF4E appears to be contingent upon
its release from its binding protein, 4E-BP1, a 22 kDTranslation, an important regulatory step in cellular
synthesis of proteins in eukaryotic cells, is a multiphase protein. 4E-BP1 bears a near total homology to phos-
process in which each phase, that is, initiation, elonga- phorylated heat- and acid-stable protein (PHAS-1) [3, 4].
4E-BP1 interferes with the formation of eIF4F complex.
The eIF4E binding sites on eIF4G (of the eIF4F com-
Key words: cell signaling, eukaryotic initiation factor 4E binding pro-
plex) and 4E-BP1 bear a common sequence containingtein-1, tubular epithelial cells, MAP kinase, protein synthesis, type 2
diabetes, proximal tubule cell. the motif, YXXXXL f , where f is a hydrophobic amino
acid, the two proteins competing for eIF4E [6]. Phos-Received for publication May 2, 2000
phorylation of 4E-BP1 may release eIF4E that is thenand in revised form September 6, 2000
Accepted for publication September 28, 2000 free to promote protein translation [4]. Three homolo-
gous cDNAs encoding distinct proteins have been clonedÓ 2001 by the International Society of Nephrology
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in mammals: 4E-BP1, 4E-BP2, and 4E-BP3 [2]. Studies mmol/L ethylene glycol-bis(b-aminoethylether)-N-tet-
raacetic acid (EGTA), 1 mmol/L phenylmethylsulfonylin nonrenal tissues have shown that insulin is a potent
regulator of both the initiation and elongation phases of fluoride (PMSF), 1 mg/mL aprotinin, and 1 mg/mL leupep-
tin. Equal amounts of cell lysates (150 mg) from controlprotein translation.
The regulation of translation has not been studied in and insulin-treated cell layers were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-the kidney, although it could play an important role in
several conditions, including renal hypertrophy caused PAGE) using an 8% gel. Proteins were transferred to
nitrocellulose membrane overnight and blocked for anby loss of nephrons or in hyperinsulinemic states such
as type II diabetes. Proximal tubular epithelial (PTE) hour in 5% nonfat milk. Following washes in Tris-buf-
fered saline containing 0.1% Tween-20 (TBST), thecells that form the bulk of renal cells in the cortex partici-
pate in renal growth seen in these conditions. As they membrane was incubated with 2 mg/mL of an antiphos-
photyrosine antibody linked to peroxidase (Transduc-are endowed with an abundance of insulin receptors in
vivo, it is likely that insulin regulates protein translation tion Laboratories, Lexington, KY, USA) for three hours.
The membranes were washed, and the bands were devel-in PTE cells. In this study, we examined the regulation
of 4E-BP1 phosphorylation by insulin in proximal tubu- oped by chemiluminescence using the enhanced chemilu-
minescence (ECL) system.lar cells in culture.
Assay for autophosphorylation of insulin receptor
METHODS
Proximal tubular epithelial cells were incubated with
Cell culture or without 1 nmol/L insulin for five minutes. Untreated
control and insulin-treated cell layers were homogenizedSV40 virus-immortalized murine proximal tubular epi-
thelial (PTE) cells (kindly provided by Dr. Eric Neilson, in the immunoprecipitation buffer as described pre-
viously in this article. Equal amounts of the homogenatesVanderbilt University, Nashville, TN, USA) were grown
in culture, as previously described [7]. The cells were (200 mg) were immunoprecipitated with 4 mg/mL of an
antibody against the b chain of the insulin receptorroutinely grown in Dulbecco’s modified Eagle’s medium
(DMEM) containing 5 mmol/L glucose and no insulin, (Santa Cruz Laboratories). A kinase reaction was per-
formed with the immunoprecipitated receptor in 50but with other additives, including HEPES and antibiot-
ics. Experiments were performed when cell layers were mmol/L HEPES, pH 7.4, 10 mmol/L manganese chloride
in the presence of 5 mCi of [g32P]-ATP for 30 minutes80 to 90% confluent.
at 308C. The reactants were separated on an 8% gel.
Measurement of de novo protein synthesis Autoradiography was performed, and bands were visual-
ized by chemiluminescence.Proximal tubular epithelial cells were quiesced in se-
rum-free medium lacking cysteine and methionine for
4E-BP1 phosphorylation assay24 hours. Cell layers were randomized for incubation for
24 hours with insulin at 150 mU/mL (1 nmol/L) or equal Proximal tubular epithelial cells were made quiescent
in serum-free media for 24 hours. Cells were then incu-volume of vehicle (control) in the presence of 10 mCi/
well of 35S-Translabel (specific activity 1175 Ci/mmol; bated with or without insulin for the indicated time peri-
ods. For studies involving inhibitors, cells were incubatedNew England Nuclear, Boston, MA, USA). Insulin levels
in the range of 1 to 2 nmol/L are physiologically relevant with inhibitors at the stated concentrations and duration,
prior to the addition of insulin. Cells were washed threeand are routinely encountered in the db/db mice with
insulin resistance and type 2 diabetes [8]. Cell layers times with PBS buffer and harvested in 1 mL of lysis
buffer containing 50 mmol/L Tris-HCl, pH 7.5, 150were washed in phosphate-buffered saline (PBS) con-
taining 10 mmol/L methionine and lysed in 0.5 mol/L mmol/L KCl, 1 mmol/L dithiothreitol, 1 mmol/L ethyl-
enediaminetetraacetic acid (EDTA), 50 mmol/L b-glyc-NaCl. Following precipitation in an equal volume of 24%
trichloroacetic acid containing 20 mmol/L methionine, erophosphate, pH 7.5, 1 mmol/L EGTA, 50 mmol/L
sodium fluoride, 0.1 mmol/L sodium orthovanadate,the precipitates were sequentially washed in 5% trichlo-
roacetic acid and ethanol, and radioactivity was counted 1 mmol/L PMSF, 2 mmol/L benzamidine, 1 mg/mL aprot-
inin, 1 mg/mL leupeptin, and 10 mg/mL soybean trypsinusing scintillation fluid.
inhibitor. The cells were lyzed by three freeze/thaw cy-
Assay for tyrosine phosphorylation of proteins cles, and cell debris was removed by centrifugation. Pro-
tein levels of the supernatants were determined usingFollowing incubation with insulin (1 nmol/L) for dif-
ferent time periods, cells were homogenized in an immu- the Bio-Rad assay. As 4E-BP1 is heat and acid stable,
these properties were utilized in its detection. Equalnoprecipitation buffer made of 50 mmol/L Tris-HCl, pH
7.4, 140 mmol/L sodium chloride, 50 mmol/L sodium amounts of protein from each sample (300 mg) were
boiled at 1008C for seven minutes followed by incubationfluoride, 1 mmol/L sodium orthovanadate, 1% NP-40, 1
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on ice for five minutes, as described [9]. Heat-treated A Sepharose beads at 48C for one hour by rotational
shaking. The beads were collected by centrifugation. Thesamples were centrifuged for five minutes at 48C, and
proteins were precipitated by adding trichloroacetic acid supernatants were incubated with a polyclonal goat anti–
4E-BP1 antibody (6 mg/mL) for three hours at 48C. Pro-to a final concentration of 15%. After incubation for
three hours at 48C, the protein precipitates were centri- tein beads (30 mL/mL) were added and incubated for
two hours at 48C by rotational shaking. Immunobeadsfuged for 10 minutes at 48C. Trichloroacetic acid was
aspirated, and 0.5 mL diethyl ether was added to the were collected by centrifugation and sequentially washed
two times in lysis buffer, immunoprecipitation buffer,precipitates, mixed, and incubated on ice for five min-
utes. Protein pellets were centrifuged for five minutes, and 200 mmol/L LiCl containing 1 mmol/L dithiothreitol.
The beads were resuspended in Laemmli buffer andand diethyl ether was removed by aspiration [4]. Pellets
were resuspended in Laemmli buffer containing 2-mer- boiled for five minutes, and proteins were separated on
a 15% gel. Proteins were transferred to nitrocellulosecaptoethanol at a concentration of 15 mg/mL. Samples
were boiled for five minutes, and proteins were separated membrane and autoradiographed.
on a 15% polyacrylamide gel followed by electrotransfer
Phosphatidylinositol 3-kinase assayto a nitrocellulose membrane using a buffer containing
Tris-HCl, glycine, and methanol for 18 hours at 35 V. Control and insulin-treated (1 nmol/L for 5, 10, 15,
and 30 min) PTE cells were homogenized in the RIPAThe nitrocellulose membrane was rinsed twice in TBST
and blocked by incubation in TBST buffer with 2% non- buffer consisting of 20 mmol/L Tris-HCl, pH 7.5, 150
mmol/L sodium chloride, 5 mmol/L EDTA, 0.1 mmol/Lfat milk powder. After rinsing twice in TBST buffer,
membranes were incubated with a polyclonal goat anti– sodium ortho-vanadate, 1 mmol/L PMSF, 0.1% aprotinin,
and 1% NP-40. Equal amounts of homogenates (100 mg)4E-BP1 antibody (1:5000, 40 ng/mL) in TBST buffer for
3.5 hours (Santa Cruz Laboratories). The membranes were immunoprecipitated using antiphosphotyrosine an-
tibody as previously described [10]. The immunobeadswere washed twice for 10 minutes in TBST buffer and
incubated with 1:10,000 dilution of donkey anti-goat anti- were incubated with 10 mg phosphatidylinositol for 10
minutes at 258C in the phosphatidylinositol 3-kinase (PIbody conjugated to peroxidase (Santa Cruz Labora-
tories) in TBST buffer for 45 minutes and washed as 3-kinase) assay buffer containing 20 mmol/L Tris-HCl,
pH 7.5, 100 mmol/L sodium chloride, 0.5 mmol/L ethyl-previously mentioned. 4E-BP1 signal was detected by
using chemiluminescence. In some experiments, phos- ene diamine-bis(b-aminoethyl ether) N,N,N9,N9-tetra-
acetic acid. Following the addition of 20 mmol/L magne-phorylation status of 4E-BP1 was assessed by Western
blotting with a specific antibody against phosphorylated sium chloride, 5 mCi of [g-32P] ATP were added to the
assay mixture, and the reactants were further incubated4E-BP1 (New England Biolabs, Beverly, MA, USA).
Preliminary experiments were performed to establish a for 10 minutes at 258C. Reaction was stopped by the
addition of a mixture of chloroform-methanol and 11.6correlation between phosphorylation of 4E-BP1 as de-
tected by change in migration of the protein as detected N HCl at a ratio of 50:100:1. The reactants were extracted
with 100 mL of chloroform, and the organic layer wasby the conventional anti–4E-BP1 antibody and staining
with the anti–phospho-4E-BP1. washed with methanol and 1 N HCl in a 1:1 ratio. The
reaction products were dried, resuspended in chloro-
Ortho-phosphate labeling assay for 4E-BP1 form, separated by thin layer chromatography, and de-
veloped with chloroform/methanol/28% ammonium hy-The method of Gingras et al was employed [9]. PTE
cells were made quiescent by 24-hour incubation in se- droxide/water in a ratio of 129:114:15:21. The spots were
visualized by autoradiography. Laser densitometry wasrum-free medium. Cells were labeled with 160 mCi/mL
of [32P]-orthophosphate (specific activity 8810 Ci/mmol; performed to assess the density of the reactant bands.
New England Nuclear) for three hours. Insulin (2 nmol/L)
Akt assaywas added, and the incubation was extended for 30 min-
utes. Cells were lyzed for 30 minutes at 48C in a buffer Equal amounts (100 mg) of PTE cell lysates from con-
trol and insulin-treated (1 nmol/L for 15 to 180 min)containing 10% glycerol, 50 mmol/L Tris (pH 7.5), 60
mmol/L KCl, 2 mmol/L trans-1,2-diaminocyclohexane PTE cells were suspended in RIPA buffer and incubated
with a sheep polyclonal anti-Akt antibody (Upstate Bio-N,N,N9,N9-tetracetic acid, 1% Triton X-100, 2 mmol/L
dithiothreitol, 20 mmol/L b glycerophosphate, and 10 technology, Lake Placid, NY, USA) at 48C for three
hours. Protein G Sepharose beads were added and incu-nmol/L okadaic acid. Total incorporated radioactivity
was determined by spotting the cell extract on DE-81 bated at 48C for one hour. The beads were washed three
times in immunoprecipitation buffer and two times infilter paper that was washed five times with 75 mmol/L
phosphoric acid and counted by scintillation counting. PBS and resuspended in Akt buffer containing 50
mmol/L Tris (pH 7.4), 10 mmol/L magnesium chloride,Equal amounts of labeled cell extract (1.5 3 106 cpm)
were precleared by incubating with 50 mL/mL of protein 25 mmol/L b-glycerophosphate, 1 mmol/L dithiothreitol,
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and 0.1 mmol/L sodium orthovanadate. The Akt reaction
was performed in the presence of 50 mmol/L cold ATP,
1 mCi of [g-32P] ATP, and myelin basic protein (MBP)
at 308C for 30 minutes. Loading buffer was added, and
samples were boiled and run on a 15% gel. Bands were
visualized by autoradiography.
Erk-1/-2–type mitogen-activated protein kinase assay
Equal amounts (100 mg) of PTE cell lysates from con-
trol and insulin-treated (1 nmol/L) cells were suspended
in RIPA buffer and incubated with a rabbit polyclonal
anti–Erk-1 antibody (Santa Cruz Laboratories) at 48C
for three hours. Protein A Sepharose beads were added
and incubated at 48C for one hour. The immunobeads
were washed three times in immunoprecipitation buffer
and two times in PBS. They were incubated for 30 min-
utes at 308C with MBP substrate, 0.5 mmol/L protein
kinase A inhibitor, 25 mmol/L cold ATP, and 1 mCi of
Fig. 1. Insulin augments de novo protein synthesis in proximal tubule
[g-32P] ATP in mitogen-activated protein (MAP) kinase epithelial (PTE) cells. PTE cells were incubated with vehicle or 1 nmol/L
insulin for 24 hours in a serum-free medium in the presence of 10 mCi/buffer. The MAP kinase buffer contained 10 mmol/L
well of 35S-Translabel, and incorporation of the label into trichloroaceticHEPES, pH 7.4, 10 mmol/L magnesium chloride, 0.5 acid-precipitable protein was estimated. Results are mean 6 SEM of
mmol/L dithiothreitol, and 0.5 mmol/L sodium orthova- three experiments. *P , 0.025.
nandate. The reaction was stopped by addition of sample
buffer. The reaction mixture was boiled for five minutes
and subjected to SDS-PAGE employing a 15% gel. The sis by 58 6 14.6% compared with untreated control cells
bands were visualized by autoradiography. Western blot- (P , 0.025; Fig. 1).
ting with anti–Erk-1 antibody was performed on an ali- As insulin binding activates tyrosine kinase activity of
quot of assay lysates to assess loading. the insulin receptor, tyrosine phosphorylation of proteins
was evaluated by an antiphosphotyrosine blot. Insulin at
Employment of kinase inhibitors 1 nmol/L induced a time-dependent increase in tyrosine
phosphorylation of several proteins that was evident atIn experiments employing inhibitors, the cell layers
15 and 30 minutes and waned by 60 minutes (Fig. 2A).were preincubated with 100 nmol/L Wortmannin or 50
Cellular proteins phosphorylated by immunoprecipi-mmol/L LY294002 or 50 or 100 mmol/L PD098059 prior
tated insulin receptor were examined in a kinase reac-to the addition of insulin. Wortmannin and LY294002
tion. To directly test the tyrosine kinase activity of theare well-characterized inhibitors of PI 3-kinase [11, 12],
insulin receptor, insulin receptor b chain was immuno-
whereas PD098059 inhibits activation of MEK 1/2, a precipitated from lysates of insulin-treated PTE cells. An
kinase that directly activates Erk-1/-2–type MAP kinase. immune complex kinase assay of the immunoprecipitates
showed phosphorylation of several proteins in the range
Statistics of approximately 180 kD to ,50 kD (Fig. 2B). The bands
The data were expressed as means 6 SEM and ana- of approximately 180, 90, 60, and 50 kD may correspond
lyzed by Student t test, with P , 0.05 being considered to insulin receptor substrate, insulin receptor b chain,
SH-PTP1 phosphatase, and Shc, respectively. These datasignificant.
suggest phosphorylation of several insulin receptor-asso-
ciated proteins by the intrinsic tyrosine kinase activity of
the receptor, including autophosphorylation, followingRESULTS
incubation with insulin.Insulin increases protein synthesis and tyrosine
phosphorylation of proteins in mouse PTE cells Insulin increases phosphorylation of 4E-BP1
The effect of insulin on the rate of incorporation of in PTE cells
35S-Translabel into trichloroacetic acid-precipitable pro- Stimulation of initiation phase of protein translation
tein was determined as an index of its effect on de novo is an important mechanism by which insulin augments
protein synthesis in PTE cells. Following 24 hours of protein synthesis. This requires phosphorylation of 4E-
BP1 in order to free eIF4E from the heterodimeric com-incubation, insulin (1 nmol/L) increased protein synthe-
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of the three isoforms, was the most phosphorylated
among the isoforms and does not bind to eIF4E. Re-
tarded migration of the b- and g-isoforms is due to phos-
phorylation of 4E-BP1. Incubation of cells with 1 nmol/L
insulin increased the proportion of the highly phosphory-
lated g isoform of 4E-BP1 compared with control cells
(Fig. 3A, lane 3 vs. lane 1).
To confirm further that insulin phosphorylates 4E-
BP1, PTE cells were labeled with ortho [32P]-phosphate
followed by incubation with insulin. The labeled cell
extracts were immunoprecipitated with anti–4E-BP1 and
subjected to SDS-PAGE and autoradiography. Insulin
caused a marked increment in the phosphorylation of
4E-BP1 compared with control untreated cells (Fig. 3B,
lane 2 vs. lane 1), confirming that insulin augments 4E-
BP1 phosphorylation in PTE cells.
PI 3-kinase mediates insulin-induced phosphorylation
of 4E-BP1
Previous studies have suggested an important role for
PI 3-kinase in the phosphorylation of 4E-BP1 in response
to serum and growth factors [9, 13, 14], although recently,
a PI 3-kinase-independent pathway has also been de-
scribed [15]. We evaluated the role of PI 3-kinase in
insulin-induced phosphorylation of 4E-BP1 by em-
ploying two structurally dissimilar PI 3-kinase inhibitors.
Cells were preincubated with Wortmannin followed by
incubation with 1 nmol/L insulin for 30 minutes. Wort-
mannin completely inhibited the insulin-induced in-
crease in 4E-BP1 phosphorylation (Fig. 3A, lane 4 vs.
lane 3). The proportion of the unphosphorylated a-iso-
form of 4E-BP1 was increased in cells treated with insulin
and Wortmannin compared with the phosphorylated iso-
Fig. 2. (A) Insulin increases tyrosine phosphorylation of proteins. PTE forms observed in cells treated with insulin alone. Basal
cells were incubated with 1 nmol/L insulin for 5 to 60 minutes. The level of 4E-BP1 phosphorylation in control cells also
cells were homogenized, and 150 mg protein from each time point
appeared to be inhibited by Wortmannin (Fig. 3A, lanewere fractionated on an 8% gel. Following transfer to nitrocellulose
membrane, immunoblotting was performed with 2 mg/mL of antiphos- 2 vs. lane 1). These results suggest that both constitutive
photyrosine antibody linked to peroxidase. Reactive bands were visual- and insulin-induced phosphorylation of 4E-BP1 in PTE
ized by chemiluminescence. Size markers are shown. A representative
cells is dependent on PI 3-kinase activation.autoradiograph from two experiments is shown. (B) Autophosphoryla-
tion of insulin receptor. PTE cells were incubated with 1 nmol/L insulin The role of PI 3-kinase in insulin regulation of 4E-
for five minutes, and 200 mg cell homogenates were immunoprecipitated BP1 phosphorylation was also evaluated by employing
with 4 mg/mL of an antibody against the b chain of the insulin receptor.
LY294002, another PI 3-kinase inhibitor. PreincubationA kinase reaction was performed with the immunoprecipitated receptor
in the presence of 5 mCi of [g32P]-ATP for 30 minutes at 308C. Reactants of PTE cells with LY294002 prevented the insulin-
were separated on an 8% gel. A representative autoradiograph from induced phosphorylation of 4E-BP1 (Fig. 3C, lane 5 vs.
two experiments is shown.
lane 4). Inhibition of 4E-BP1 phosphorylation by
LY294002 further confirmed the requirement of PI-3-
kinase activation in phosphorylation of 4E-BP1 by insu-
lin in PTE cells.plex. Accordingly, the effect of insulin on 4E-BP1 phos-
phorylation in PTE cells was examined. Three isoforms To confirm directly that insulin augmented PI 3-kinase
activity in PTE cells, we measured the activity of theof 4E-BP1 could be observed on a Western blot [3]: (1)
A fast-moving and unphosphorylated a-isoform, which kinase in antiphosphotyrosine immunoprecipitates of
PTE cells incubated with or without 1 nmol/L insulin.binds to eIF4E with greatest affinity among the isoforms.
(2) A b-isoform was hypophosphorylated and migrated A time-dependent increase in PI 3-kinase activity was
seen by 10 minutes, was maximal at 15 minutes, andslower than the a form. The b isoform binds to eIF4E
with low affinity. (3) The g isoform, the slowest migrating persisted for 30 minutes (Fig. 3D).
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b
Fig. 3. (A) Insulin-induced 4E-BP1 phosphorylation is PI 3-kinase de-
pendent. PTE cells were incubated with medium vehicle (control) or
1 nmol/L insulin for 30 minutes with or without preincubation for two
hours with 100 nmol/L Wortmannin, a PI 3-kinase inhibitor. The cell
homogenates were processed for 4E-BP1 expression by Western blot-
ting as described in the Methods section. A representative autoradio-
graph from eight experiments is shown. (B) Insulin augments phosphor-
ylation of 4E-BP1–Ortho [32P]-phosphate labeling. PTE cells were
quiesced in serum-free medium and labeled with 160 mCi/mL of ortho
[32P]-phosphate for three hours. Cells were incubated with or without
2 nmol/L insulin for 30 minutes with simultaneous labeling. Cells were
lysed, and an equal amount of radioactivity was immunoprecipitated
with 4E-BP1 antibody. Immunoprecipitates were run on a 15% gel,
transferred to a nitrocellulose membrane, and autoradiographed. A
representative autoradiograph from two experiments is shown. (C) Insu-
lin-induced 4E-BP1 phosphorylation is PI 3-kinase and Erk-1/-2 kinase
dependent. PTE cells were incubated with medium vehicle (control)
or 1 nmol/L insulin for 30 minutes with or without preincubation for
two hours with 50 mmol/L LY294002, a PI 3-kinase inhibitor, or 100
mmol/L PD098509, an inhibitor of MEK. The cell homogenates were
processed for 4E-BP1 expression by Western blotting as described in
A. A representative autoradiograph from more than three experiments
is shown. (D) Insulin increases PI 3-kinase activity in PTE cells. Follow-
ing incubation with vehicle or insulin (1 nmol/L) for 5 to 30 minutes,
cell layers were homogenized, and equal amounts of homogenates
(100 mg) were immunoprecipitated with antiphosphotyrosine antibody.
Immunoprecipitates were processed for PI 3-kinase activity, as de-
scribed in the Methods section. A representative autoradiograph from
three experiments is shown.
(PKB), a serine/threonine kinase with pleckstrin homol-
ogy domain at its amino terminus [17]. Activity of Akt
was evaluated by an immune complex kinase assay in
which the ability of immunoprecipitated Akt to phos-
phorylate MBP substrate was studied. Insulin (1 nmol/L)
robustly induced Akt activity that was evident at 15 min-
utes and was sustained for up to two hours (Fig. 4A,
lanes 2 through 5 vs. 1).
mTOR mediates insulin-induced phosphorylation
of 4E-BP1 in PTE cells
Mammalian target of rapamycon (mTOR; RAFT1,
FRAP) has been implicated in the phosphorylation of
4E-BP1 as a result of activation of PI 3-kinase-dependent
and -independent pathways [9, 15, 18]. mTOR belongs
to the phosphoinositide kinase-related (PIK) family of
kinases, which includes ataxia telangiectasia and mutated
proteins, and its activation may occur downstream of Akt
[19]. We next examined mTOR involvement in insulin-
induced activation of 4E-BP1 in PTE cells by employing
rapamycin, an inhibitor of mTOR. Preincubation with
rapamycin inhibited the insulin-induced phosphoryla-
tion of 4E-BP1 (Fig. 4B, lane 4 vs. lane 2), indicating
that mTOR activation is involved in phosphorylation ofInsulin activates Akt in PTE cells
4E-BP1 in response to insulin.
Phosphatidylinositol 3-kinase catalyzes the phosphor-
Erk-1/-2–type MAP kinase pathway is involvedylation of lipid substrates, such as phosphatidylinositol
in insulin-induced activation of 4E-BP1in the D-3 position of the inositol ring [16], that bind to
proteins with pleckstrin homology domains. Important Conflicting data have been reported on the role of
Erk-1/-2–type MAP kinase in 4E-BP1 phosphorylation,among the downstream targets of PI 3-kinase is Akt
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Fig. 4. (A) Insulin stimulates Akt activity in PTE cells. PTE cells were
incubated with medium vehicle or insulin (1 nmol/L) for 15 to 180
minutes. Equal amounts of cell homogenates (100 mg) were immunopre-
cipitated with Akt antibody, and the immunoprecipitates were em-
ployed in a kinase reaction using myelin basic protein (MBP) as a
substrate. The reaction products were run on a 15% gel and autoradio-
graphed. A representative autoradiograph from three experiments is
shown. (B) Insulin-induced 4E-BP1 phosphorylation is mTOR depen-
dent. PTE cells were incubated with medium vehicle (control) or
1 nmol/L insulin for 30 minutes with or without preincubation for
two hours with 22 nmol/L rapamycin, a mTOR inhibitor. The cell
homogenates were processed for 4E-BP1 by Western blotting as de-
scribed in Figure 3. A representative autoradiograph from more than
10 experiments is shown.
Fig. 5. Insulin-induced phosphorylation of 4E-BP1 is dependent on
Erk-1/-2 type MAP kinase in PTE cells. (A) Cell layers were incubatedsuggesting a tissue-specific role for the kinase [20–23].
with vehicle, or insulin, with or without preincubation with 50 mmol/LWe examined whether Erk-1/-2 activation was involved or 100 mmol/L PD098059 for 30 minutes. Equal amounts (300 mg)
in insulin stimulation of 4E-BP1 phosphorylation in PTE of cell layers were fractionated on 15% SDS PAGE, transferred to
nitrocellulose membrane, and immunoblotted with an antibody againstcells by employing PD098059, an inhibitor of MEK, the
phospho-4E-BP1 that only recognizes phosphorylated form of protein.enzyme upstream of Erk-1/-2–type MAP kinase. Prein- The lower panel shows Western blotting with anti–4E-BP1 that was
cubation with PD098059 prevented the increase in phos- done to assess loading. (B) Insulin increases the activity of Erk-1/-2
type MAP kinase in PTE cells. Cell layers were incubated with vehicle,phorylation of 4E-BP1 caused by 1 nmol/L insulin (Fig.
or insulin, with or without preincubation with 50 mmol/L or 100 mmol/L3C, lane 6 vs. lane 4), suggesting involvement of MEK- PD098059 for 30 minutes. Equal amounts (100 mg) of control and insulin
Erk-1/-2 MAP kinase pathway. Dose–response studies (1 nmol/L)-treated cell layers were immunoprecipitated with an anti-
Erk-1/-2–type MAP kinase antibody. The immunoprecipitates wereshowed that modest inhibition occurred at 50 mmol/L,
employed in an immune complex kinase assay with MBP as a substrate.although maximal inhibition of insulin-induced 4E-BP-1 MBP was separated on a 15% SDS polyacrylamide gel and visualized
phosphorylation required 100 mmol/L PD098059 (Fig. 5A). by autoradiography. Western blotting with anti-Erk-1/-2 MAP kinase
antibody was performed with an aliquot of lysates to assess loadingWe sought direct confirmation of the activation of
(lower panel). (C) Insulin-induced activity of Erk-1/-2–type MAP kinaseErk-1/-2–type MAP kinase by insulin by an in vitro ki- is PI 3-kinase dependent. Cell layers were incubated with vehicle, or
nase assay using MBP as a substrate. Insulin (1 nmol/L) insulin, with or without preincubation with 50 mmol/L of LY294002 for
two hours. Erk-1/-2–type MAP kinase activity (top panel) and loadingmarkedly increased the activity of Erk-1/-2 type MAP
of proteins by Western blotting (bottom panel) were assessed as de-kinase (Fig. 5B, lane 2 vs. lane 1). The dependence of scribed in this article. A representative autoradiograph from two experi-
insulin stimulation of Erk on MEK-1/2 kinase activation ments is shown.
was examined by preincubation with PD098059. Similar
to the observations with inhibition of insulin-induced
phosphorylation of 4E-BP1, inhibition of insulin-induced
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Fig. 6. Schematic of the potential signaling
pathways involved in insulin-induced phosphor-
ylation of 4E-BP1 in PTE cells.
Erk-1/-2 kinase activation was partial at 50 mmol/L, with renal cell systems. This study reports our initial findings
on insulin regulation of protein translation in PTE cells.maximal inhibition requiring 100 mmol/L concentration
Insulin, in nmol/L concentrations, increased the phos-of the inhibitor (Fig. 5B).
phorylation of 4E-BP1 in PTE cells in association withWe have shown that PI 3-kinase activation is required
stimulation of de novo protein synthesis (Fig. 3). Preincu-for insulin stimulation of 4E-BP1 phosphorylation (Fig.
bation with two structurally dissimilar PI 3-kinase inhibi-3 A, C). Furthermore, Erk-1/-2–type MAP kinase activa-
tors, Wortmannin and LY294002, abolished the insulintion also appears to be involved in insulin augmentation
induced 4E-BP1 phosphorylation, demonstrating the re-of 4E-BP1 phosphorylation. Therefore, we next exam-
quirement of PI 3-kinase activation (Fig. 3). Activationined whether PI 3-kinase stimulates Erk-1/-2–type MAP
of Akt occurs downstream of PI 3-kinase and has beenkinase in insulin-treated PTE cells. Preincubation of PTE
reported to be required for 4E-BP1 activation by insulincells with LY294002 abolished insulin-induced stimula-
[9]. Under conditions that led to 4E-BP1 phosphoryla-tion of Erk-1/-2 activity (Fig. 5C, lane 4 vs. lane 3). These
tion, insulin stimulated Akt activity in PTE cells. Aktdata show that Erk-1/-2–type MAP kinase activation by
activates a number of downstream targets, which mayinsulin is PI 3-kinase-dependent in PTE cells.
include mTOR [19]. The potential role of mTOR in the
phosphorylation of 4E-BP1 was evaluated by employing
DISCUSSION its inhibitor, rapamycin. Rapamycin binds to an intracel-
Control of protein translation by insulin has been stud- lular receptor, the FK binding protein-12, and the FKBP-
ied in a variety of cells and organ systems. Although rapamycin complex inhibits the activity of mTOR [24].
kidney is an insulin-sensitive organ and several functions Inhibition of insulin-stimulated 4E-BP1 phosphorylation
of PTE cells are regulated by insulin, this important by rapamycin (Fig. 4) suggests involvement of mTOR
regulatory mechanism of protein synthesis has not been (Fig. 6). However, it is unclear from these data whether
mTOR has a direct role in 4E-BP1 phosphorylation orextensively studied in either the kidney or in in vitro
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activates a downstream kinase in insulin-stimulated PTE in insulin regulation of 4E-BP1 phosphorylation in PTE
cells. In vitro observations suggest that mTOR immuno- cells are summarized in Figure 6.
precipitates can phosphorylate 4E-BP1 and 4E-BP2 Increased protein translation could be important in
[25, 26]. p70s6 kinase is a potential target of mTOR, renal diseases associated with hyperinsulinemia. Regula-
although recent evidence has refuted a role for it in 4E- tion by protein translation is particularly relevant to con-
BP1 phosphorylation [27]. ditions in which an increase in cell/tissue content of a
Insulin-stimulated 4E-BP1 phosphorylation was abol- protein is accompanied by either no change or a reduc-
ished by PD098059, implying that MEK and its down- tion in its mRNA level. Such a dissociation between
stream target, Erk-1/-2–type MAP kinase, are involved. mRNA level and increase in its corresponding protein
The role for MAP kinase in 4E-BP1 phosphorylation is content in the kidney has been recently reported in type
controversial [28]. In vitro studies have shown that MAP 2 diabetes, for example, glomerular p27kip1 [32], and renal
kinase phosphorylates ser64 of 4E-BP1 [29]. Observations laminin [33]. Thus, it is conceivable that increase in renal
in hematopoietic cells and prostaglandin F2a-treated content of p27kip1 and laminin in type 2 diabetes involves
smooth muscle cells also showed involvement of Erk- insulin-driven protein translation. Augmented protein
type MAP kinase in 4E-BP1 phosphorylation [20, 21]. translation may contribute to increased protein and ma-
However, in other cell types, Erk-type MAP kinase was trix synthesis in the renal cortex in type 2 diabetes, where
found to have no role in 4E-BP1 phosphorylation [13, PTE cells are prime targets of insulin. In support of
22, 23]. Taken together, these data suggest that kinase this notion, we have observed that insulin receptor is
pathways involved in 4E-BP1 phosphorylation may be activated in the renal cortex in the early, hyperinsulin-
specific for the cell type and the agonist under consider- emic phase of type 2 diabetes at a time when matrix
ation. accumulation is evident in the tubulointerstitial compart-
In PTE cells, inhibition of insulin-induced 4E-BP1 ment (abstract; Feliers et al, J Am Soc Nephrol 10:679A,
phosphorylation by MEK inhibitors suggests an involve- 1999). Altered regulation of protein translation could
ment of Erk-1/-2–type MAP kinase activation. Insulin be involved in diabetic nephropathy and compensatory
stimulation of Erk-1/-2–type MAP kinase activity in PTE renal growth and be potentially involved in apoptosis,
cells was directly confirmed in an immunokinase assay growth abnormalities, and carcinogenesis in the kidney
(Fig. 5) and could involve two potential mechanisms. [2, 34].
Phosphorylated insulin receptor could recruit Shc, which
in turn activates Erk-1/-2–type MAP kinase via the Ras, ACKNOWLEDGMENTS
Raf, MEK-1/-2 pathway (Fig. 6). The other mechanism,
This study was supported by funding from the American Diabetesreported in insulin-treated myeloid cells, could involve
Association (BSK), Veterans’ Administration Research Service (Meritstimulation of PKC-z in a PI 3-kinase-dependent man- and REAP awards for B.S.K., H.E.A., and G.G.C.), and the National
ner; PKC-z may, in turn, activate Erk-1/-2 activity (Fig. 6) Institutes of Health (G.G.C. and H.E.A.).
[30]. In the present study, insulin activation of Erk-1/-2
Reprint requests to B. S. Kasinath, M.D., Division of Nephrology,could be inhibited by LY294002, demonstrating that in- Mail code 7882, University of Texas Health Science Center, 7703 Floyd
sulin-stimulated Erk-1/-2–type MAP kinase activation is Curl Drive, San Antonio, Texas 78229-3900, USA.
E-mail: kasinath@uthscsa.eduPI 3-kinase-dependent in PTE cells. Similar regulation of
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APPENDIXcross-talk between PI 3-kinase and Erk-1/-2–type MAP
Abbreviations used in this article are: ATP, adenosine 59-triphos-kinase pathways in insulin-stimulated 4E-BP1 phosphory-
phate; 4E-BP1, 4E binding protein-1; eIF4E, eukaryotic initiation fac-lation in PTE cells, including contribution of PKC, need tor 4E; FKBP, FK binding protein; FRAP, FKBP12 and rapamycin
to be elucidated. associated protein; IRS, insulin receptor substrate; MAP kinase, mito-
gen-activated protein kinase; MBP, myelin basic protein; mTOR, mam-In this study, we have addressed the role of kinases
malian target of rapamycin; PHAS, phosphorylated heat and acid stablein phosphorylation of 4E-BP1. However, it should be
protein; PI 3-kinase, phosphatidylinositol 3-kinase; PIK, phosphoinosi-
emphasized that increase in 4E-BP1 phosphorylation by tide kinase related; PTE, proximal tubule epithelial; RAFT1, rapa-
mycin and 12-kD FK506 binding protein target-1; TBST, Tris bufferedinsulin may be modulated by decreased activity of phos-
saline containing Tween 20; UTR, untranslated region.phatases. For instance, PTEN has been shown to de-
phosphorylate phosphatidylinositol 3,4,5-trisphosphate
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